The great escape - AIDS viruses and immune control

Nature Medicine

Volumn 5, Issue 11, 1999, Pages 1233-1235

  Goulder, Philip J R ^a   Walker, Bruce D ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; ANTIGENIC VARIATION; ANTIVIRAL ACTIVITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EPITOPE MAPPING; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOREGULATION; IMMUNOSURVEILLANCE; MACACA; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; VIRUS MUTATION;

ANIMALS; DISEASE PROGRESSION; EPITOPES; HIV CORE PROTEIN P24; HIV-1; LONGITUDINAL STUDIES; MACACA; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0032696446     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/15184     Document Type: Short Survey

References (16)

1. Ogg, G.S. et al. Quantitaten of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279, 2103-2106 (1998).
2. Schmitz, I.E. et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 277, 333-338 (1999).
3. Evans, D.T. et al. Virus-specific CTL responses select for amino-acid variation in Env and Nef. Nature Med. 5, 1270-1276 (1999).
4. Phillips, R.E. et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354, 453-459 (1991).
5. Brander, C. & Walker, B.D. The HLA class I restricted CTL response in HIV infection: systematic identification of optimal epitopes. In: HIV Molecular Immunology Database. (eds. Korber, B.T.M. et al.) 14-26 (Los Alamos National Laboratory Press, Los Alamos, New Mexico, 1998)
6. Ossendorp, F. et al. A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation. Immunity 5, 115-124 (1996).
7. Brander, C. et al. Efficient processing of the immunodominant, HLA-A*0201 restricted HIV-1 CTL epitope despite multiple variations in the epitope flanking sequences. J. Virol. (in the press).
8. Goulder, P.J.R. et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nature Med. 3, 212-217 (1997).
9. Koenig, S. et al. Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression. Nature Med. 1, 330-336 (1995).
10. Borrow, P. et al. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nature Med. 3, 205-211 (1997).
11. Price, D.A. et al. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc. Natl. Acad. Sci. USA 94, 1890-1895 (1997).
12. Rosenberg, E.S. et al. Vigorous HIV-1-specific CD4+ T-cell responses associated with control of viraemia. Science 278, 1447-1450 (1997).
13. Kalams, S.A. et al. Association between virus-specific CTL and helper responses in HIV-I infection, J. Virol. 73, 6715-6720 (1999).
14. Carrington, M. et al. HLA and HIV-1: Heterozygote advantage and B*35-Cw*04 disadvantage. Science 283, 1748-1752 (1999).
15. Dhodapkar, M.V. et al. Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells. J. Clin. Invest. 104, 173-180 (1999).
16. Kaslow, R.A. et al. Influence of human MHC genes on the course of HIV infection. Nature Med. 2, 405-411 (1996).